Last reviewed · How we verify

NCT05966558

Cesarean Section Scar Niche: The Impact on Assisted Reproductive Technology Outcome

Status unknown Last updated 28 July 2023
What this trial tests

trial in Cesarean Section Niche Impact on ART in 266 participants. Status unknown.

Timeline
22 January 2020
Primary endpoint
1 September 2024
1 October 2024

Quick facts

Lead sponsorZagazig University
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment266
Start date22 January 2020
Primary completion1 September 2024
Estimated completion1 October 2024
Sites1 location across Egypt

Conditions studied

Sponsor

Zagazig University

Who can join

Adults 18 to 37, female only, with Cesarean Section Niche Impact on ART. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

the presence of cesarean section niche has adverse effects on success of ART outcome

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Zagazig University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05966558.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing